Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1706 | 704 | 0.1431 | 0.1375 | 0.4127 | 0.4603 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 3 | 1101 | 702 | 0.0662 | 0.0722 | 0.6376 | 0.5757 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 5229 | 702 | 0.7507 | 0.7398 | 0.1343 | 0.1305 |
COLO 858 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 2 | 1178 | 702 | 0.1100 | 0.1085 | 0.5959 | 0.5981 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1602 | 701 | 0.2735 | 0.2031 | 0.4376 | 0.4582 |
WM-115 | Vemurafenib | (+)-JQ1 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1263 | 699 | 0.1730 | 0.1677 | 0.5534 | 0.5580 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3469 | 698 | 0.4595 | 0.4677 | 0.2012 | 0.1974 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1178 | 697 | 0.0571 | 0.0598 | 0.5917 | 0.6178 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 5271 | 697 | 0.7585 | 0.7398 | 0.1322 | 0.1305 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 726 | 696 | 0.0051 | 0.0054 | 0.9587 | 0.9547 |
WM-115 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1659 | 693 | 0.2769 | 0.2677 | 0.4177 | 0.4255 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 790 | 691 | 0.0179 | 0.0248 | 0.8747 | 0.8407 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 810 | 688 | 0.0207 | 0.0199 | 0.8494 | 0.8770 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 833 | 687 | 0.0263 | 0.0248 | 0.8247 | 0.8407 |
WM-115 | Vemurafenib | I-BET | 1.000 | 1.000 | uM | 72 | hr | 3 | 1611 | 687 | 0.2651 | 0.3008 | 0.4264 | 0.4036 |
A-375 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 1 | 2097 | 686 | 0.1020 | 0.0884 | 0.3271 | 0.3475 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1227 | 686 | 0.0773 | 0.0722 | 0.5591 | 0.5817 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 1 | 1246 | 683 | 0.0934 | 0.0962 | 0.5482 | 0.5276 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 736 | 681 | 0.0093 | 0.0093 | 0.9253 | 0.9244 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1988 | 681 | 0.2872 | 0.2848 | 0.3426 | 0.3145 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1897 | 677 | 0.3045 | 0.2911 | 0.3569 | 0.3460 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1051 | 677 | 0.0634 | 0.0618 | 0.6441 | 0.6473 |
WM-115 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 1 | 1801 | 675 | 0.2848 | 0.2705 | 0.3748 | 0.4169 |
COLO 858 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 1 | 1176 | 674 | 0.1152 | 0.1069 | 0.5731 | 0.5774 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 2 | 921 | 673 | 0.0447 | 0.0514 | 0.7307 | 0.7028 |